Sale!

Buy 150 mg fluvoxamine oral capsule extended release online

$198.20

150 mg fluvoxamine oral capsule,extended release
$198.28 for 30 capsules
QuantityPer unitPrice
30$6.61$198.28

Buy 150 mg fluvoxamine oral capsule extended release online. Fluvoxamine, also known by the brand names Luvox and Fevarin, is a selective serotonin reuptake inhibitor antidepressant. It’s used to treat major depressive disorder and obsessive–compulsive disorder, but it’s also used to treat anxiety disorders like panic disorder, social anxiety disorder, and post-traumatic stress disorder.

Usual Adult Dose for Obsessive Compulsive Disorder

Dosage for the immediate-release pill is 50 mg orally once a day before sleep.
100 mg orally once a day at bedtime for the first extended-release capsule dosage
100 to 300 mg orally each day as a maintenance dose
Maximum daily dose: 300 mg

-If tolerated, the dose can be increased by 50 mg every 4 to 7 days until the maximal therapeutic benefit is attained.

If the total daily dose exceeds 100 mg, it should be divided into two doses. The greater dose should be administered at bedtime if the doses are not equal.

Obsessions and compulsions in patients with obsessive compulsive disorder (OCD) as defined by DSM-III-R or DSM-IV.

Usual Pediatric Dose for Obsessive Compulsive Disorder

8 to 11 years:

-Begin with a 25 mg dose taken once a day at bedtime.
-Maximum dose: 200 mg/day -Maintenance dose: 25 to 200 mg orally each day

11–17 years old:
-Begin with a 25 mg dose taken once a day at bedtime.
-Maximum dose: 300 mg/day -Maintenance dose: 25 to 300 mg orally each day

Comments: The dose can be increased by 25 mg every 4 to 7 days, up to a maximum daily dose, as tolerated.

More than 50 mg of total daily dose should be divided into two doses. The greater dose should be administered at bedtime if the two divided doses are not equal.
-In female patients, lower doses may be more beneficial than in male ones.

Treatment of obsessive-compulsive disorder (OCD) in individuals diagnosed with DSM-III-R or DSM-IV.

Liver Dose Adjustments

Liver dysfunction:
-Immediate-release tablets: Patients should start with a low dose and gradually increase it while being closely monitored.
-Extended-release capsules: After the initial dose of 100 mg, it may be necessary to titrate gently.

Dose Adjustments

Elderly patients: Buy 150 mg fluvoxamine oral capsule extended release online

-Immediate-release tablets: Patients should start with a low dose and gradually increase it while being closely monitored.
-Extended-release capsules: After the initial dose of 100 mg, it may be necessary to titrate gently.

Patients taking multiple drugs with the potential for interactions may benefit from a lower or less frequent dose.
-Alprazolam: Starting doses of alprazolam should be reduced by at least half, and treatment should be titrated to the lowest effective dose.
Coadministration of diazepam should be avoided.

Changing from an MAOI to a non-MAOI:

-From an MAOI used to treat psychiatric disorders: Give this medicine at least 14 days before starting it.
-If you’re taking an MAOI to treat psychiatric illnesses, wait at least 14 days after finishing the other medication before starting the MAOI.
-Use with linezolid or IV methylene blue: If treatment is absolutely essential, cease this drug immediately and monitor the patient for serotonin syndrome symptoms for 14 days or until 24 hours after the last linezolid/IV methylene blue dosage, whichever comes first. The linezolid/IV methylene blue treatment can be continued 24 hours after the last dosage.
—-There is no known link between serotonin syndrome and oral/local injections of methylene blue or IV dosages of this drug less than 1 mg/kg.

Treatment discontinuation:

When possible, a progressive dose reduction rather than an abrupt discontinuation is recommended. If symptoms become intolerable, consider resuming the previously prescribed dose; discontinuation/dose reduction may continue, but at a slower pace.

Precautions

US BOXED WARNINGS:
SUICIDALITY AND ANTIDEPRESSANTS:

In short-term investigations of major depressive disorder (MDD) and other psychiatric diseases, antidepressants raised the likelihood of suicide thinking and behaviour (suicidality) in children, adolescents, and young adults when compared to placebo.

If this or any other antidepressant is to be used in a child, adolescent, or young adult, the risk must be weighed against the therapeutic need. Antidepressants did not raise the risk of suicidality in individuals over the age of 24 when compared to placebo in short-term studies, but they did reduce the risk in adults 65 and older when compared to placebo.

Depression and a variety of other psychiatric conditions have been linked to an increased risk of suicide.

Patients of all ages who begin antidepressant therapy should be closely monitored and examined for clinical deterioration, suicidality, or unexpected behavioural changes.

Families and caregivers should be informed about the importance of close monitoring and communication with the prescribing physician.

Except for adults with obsessive compulsive disorder, this medicine is not licenced for use in children (OCD).

The safety and efficacy of the drug in children under the age of eight years has yet to be determined.

Other Comments

Advice from the administration:

-This medication should not be chewed and should be eaten whole.
-Patients should be kept on the lowest effective dose as long as possible.
-Depression treatment should be continued for at least 6 months to confirm that individuals are symptom-free.

In individuals with obsessive compulsive disorder, treatment may be extended beyond 10 weeks in responding patients, and the necessity for treatment should be evaluated on a regular basis.

General

-There is no evidence that using non-IV methylene blue formulations or IV doses less than 1 mg/kg increases the risk of serotonin syndrome.

Monitoring:

Psychiatric: Patients should be watched for withdrawal symptoms as well as the appearance and deepening of suicidal thoughts.
-Neurologic: Serotonin syndrome symptoms should be examined in patients.
-Cardiovascular: Patients should have their blood pressure checked on a regular basis.

Patient advice:

-Patients should inform their healthcare provider about all medications they are taking, including prescription and non-prescription.

Suicidal thoughts and conduct are possible side effects of this medication. Patients should be on the lookout for the onset or development of depression symptoms, any unusual changes in mood or behaviour, or the appearance of suicide thoughts, actions, or self-harming impulses. Patients should notify their healthcare physician as soon as possible if they see any concerning behaviour.

There has been a report of somnolence. Driving and operating machinery should be done with caution until the individual response to the medicine is known.

If a patient is pregnant, intends to become pregnant, or is breastfeeding, they should be recommended to consult with a healthcare provider. Buy 150 mg fluvoxamine oral capsule extended release online

Category:

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.